Cargando…

Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway

BACKGROUND: Pulmonary hypertension (PH) is a progressive and fatal cardiopulmonary disease characterized by pulmonary vascular remodeling and increased pulmonary vascular resistance and artery pressure. Vascular remodeling is associated with the excessive cell proliferation and migration of pulmonar...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Haitao, Zhang, Sha, Liu, Yi, Ma, Jing, Chen, Wei, Yin, Tao, Li, Tongbin, Liang, Bin, Tao, Ling
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389662/
https://www.ncbi.nlm.nih.gov/pubmed/35986277
http://dx.doi.org/10.1186/s12931-022-02124-4
_version_ 1784770507642503168
author Liu, Haitao
Zhang, Sha
Liu, Yi
Ma, Jing
Chen, Wei
Yin, Tao
Li, Tongbin
Liang, Bin
Tao, Ling
author_facet Liu, Haitao
Zhang, Sha
Liu, Yi
Ma, Jing
Chen, Wei
Yin, Tao
Li, Tongbin
Liang, Bin
Tao, Ling
author_sort Liu, Haitao
collection PubMed
description BACKGROUND: Pulmonary hypertension (PH) is a progressive and fatal cardiopulmonary disease characterized by pulmonary vascular remodeling and increased pulmonary vascular resistance and artery pressure. Vascular remodeling is associated with the excessive cell proliferation and migration of pulmonary artery smooth muscle cells (PASMCs). In this paper, the effects of heat shock protein-110 (HSP110) on PH were investigated. METHODS: The C57BL/6 mice and human PASMCs (HPASMCs) were respectively exposed to hypoxia to establish and simulate PH model in vivo and cell experiment in vitro. To HSP110 knockdown, the hypoxia mice and HPASMCs were infected with adeno-associated virus or adenovirus carring the shRNAs (short hairpin RNAs) for HSP110 (shHSP110). For HSP110 and yes-associated protein (YAP) overexpression, HPASMCs were infected with adenovirus vector carring the cDNA of HSP110 or YAP. The effects of HSP110 on PH development in mice and cell proliferation, migration and autophagy of PASMCs under hypoxia were assessed. Moreover, the regulatory mechanisms among HSP110, YAP and TEA domain transcription factor 4 (TEAD4) were investigated. RESULTS: We demonstrated that expression of HSP110 was significantly increased in the pulmonary arteries of mice and HPASMCs under hypoxia. Moreover, knockdown of HSP110 alleviated hypoxia-induced right ventricle systolic pressure, vascular wall thickening, right ventricular hypertrophy, autophagy and proliferation of PASMCs in mice. In addition, knockdown of HSP110 inhibited the increases of proliferation, migration and autophagy of HPASMCs that induced by hypoxia in vitro. Mechanistically, HSP110 knockdown inhibited YAP and transcriptional co-activator with PDZ-binding motif (TAZ) activity and TEAD4 nuclear expression under hypoxia. However, overexpression of HSP110 exhibited the opposite results in HPASMCs. Additionally, overexpression of YAP partially restored the effects of shHSP110 on HPASMCs. The interaction of HSP110 and YAP was verified. Moreover, TEAD4 could promote the transcriptional activity of HSP110 by binding to the HSP110 promoter under hypoxia. CONCLUSIONS: Our findings suggest that HSP110 might contribute to the development of PH by regulating the proliferation, migration and autophagy of PASMCs through YAP/TAZ-TEAD4 pathway, which may help to understand deeper the pathogenic mechanism in PH development.
format Online
Article
Text
id pubmed-9389662
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-93896622022-08-20 Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway Liu, Haitao Zhang, Sha Liu, Yi Ma, Jing Chen, Wei Yin, Tao Li, Tongbin Liang, Bin Tao, Ling Respir Res Research BACKGROUND: Pulmonary hypertension (PH) is a progressive and fatal cardiopulmonary disease characterized by pulmonary vascular remodeling and increased pulmonary vascular resistance and artery pressure. Vascular remodeling is associated with the excessive cell proliferation and migration of pulmonary artery smooth muscle cells (PASMCs). In this paper, the effects of heat shock protein-110 (HSP110) on PH were investigated. METHODS: The C57BL/6 mice and human PASMCs (HPASMCs) were respectively exposed to hypoxia to establish and simulate PH model in vivo and cell experiment in vitro. To HSP110 knockdown, the hypoxia mice and HPASMCs were infected with adeno-associated virus or adenovirus carring the shRNAs (short hairpin RNAs) for HSP110 (shHSP110). For HSP110 and yes-associated protein (YAP) overexpression, HPASMCs were infected with adenovirus vector carring the cDNA of HSP110 or YAP. The effects of HSP110 on PH development in mice and cell proliferation, migration and autophagy of PASMCs under hypoxia were assessed. Moreover, the regulatory mechanisms among HSP110, YAP and TEA domain transcription factor 4 (TEAD4) were investigated. RESULTS: We demonstrated that expression of HSP110 was significantly increased in the pulmonary arteries of mice and HPASMCs under hypoxia. Moreover, knockdown of HSP110 alleviated hypoxia-induced right ventricle systolic pressure, vascular wall thickening, right ventricular hypertrophy, autophagy and proliferation of PASMCs in mice. In addition, knockdown of HSP110 inhibited the increases of proliferation, migration and autophagy of HPASMCs that induced by hypoxia in vitro. Mechanistically, HSP110 knockdown inhibited YAP and transcriptional co-activator with PDZ-binding motif (TAZ) activity and TEAD4 nuclear expression under hypoxia. However, overexpression of HSP110 exhibited the opposite results in HPASMCs. Additionally, overexpression of YAP partially restored the effects of shHSP110 on HPASMCs. The interaction of HSP110 and YAP was verified. Moreover, TEAD4 could promote the transcriptional activity of HSP110 by binding to the HSP110 promoter under hypoxia. CONCLUSIONS: Our findings suggest that HSP110 might contribute to the development of PH by regulating the proliferation, migration and autophagy of PASMCs through YAP/TAZ-TEAD4 pathway, which may help to understand deeper the pathogenic mechanism in PH development. BioMed Central 2022-08-19 2022 /pmc/articles/PMC9389662/ /pubmed/35986277 http://dx.doi.org/10.1186/s12931-022-02124-4 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Liu, Haitao
Zhang, Sha
Liu, Yi
Ma, Jing
Chen, Wei
Yin, Tao
Li, Tongbin
Liang, Bin
Tao, Ling
Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
title Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
title_full Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
title_fullStr Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
title_full_unstemmed Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
title_short Knockdown of HSP110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of YAP/TAZ-TEAD4 pathway
title_sort knockdown of hsp110 attenuates hypoxia-induced pulmonary hypertension in mice through suppression of yap/taz-tead4 pathway
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9389662/
https://www.ncbi.nlm.nih.gov/pubmed/35986277
http://dx.doi.org/10.1186/s12931-022-02124-4
work_keys_str_mv AT liuhaitao knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT zhangsha knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT liuyi knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT majing knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT chenwei knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT yintao knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT litongbin knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT liangbin knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway
AT taoling knockdownofhsp110attenuateshypoxiainducedpulmonaryhypertensioninmicethroughsuppressionofyaptaztead4pathway